rbfox-1 antibody (Merck KGaA)
Structured Review
Rbfox 1 Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbfox-1/rbfox+1+antibody/pm34880207-272-17-19
Average 90 stars, based on 1 article reviews
Images
Related Articles
Immunostaining:Article Title: MiRNA-132/212 regulates tight junction stabilization in blood–brain barrier after stroke Article Snippet: The following antibodies were used: CRTC1 (1:1000; Cell Signaling Technology, Danvers, MA, USA); TJAP-1 (1:1000; Novus Biologicals); Lactate Dehydrogenase Assay:Article Title: MiRNA-132/212 regulates tight junction stabilization in blood–brain barrier after stroke Article Snippet: The following antibodies were used: CRTC1 (1:1000; Cell Signaling Technology, Danvers, MA, USA); TJAP-1 (1:1000; Novus Biologicals); Western Blot:Article Title: MiRNA-132/212 regulates tight junction stabilization in blood–brain barrier after stroke Article Snippet: The following antibodies were used: CRTC1 (1:1000; Cell Signaling Technology, Danvers, MA, USA); TJAP-1 (1:1000; Novus Biologicals); Luciferase:Article Title: MiRNA-132/212 regulates tight junction stabilization in blood–brain barrier after stroke Article Snippet: The following antibodies were used: CRTC1 (1:1000; Cell Signaling Technology, Danvers, MA, USA); TJAP-1 (1:1000; Novus Biologicals); Activity Assay:Article Title: MiRNA-132/212 regulates tight junction stabilization in blood–brain barrier after stroke Article Snippet: The following antibodies were used: CRTC1 (1:1000; Cell Signaling Technology, Danvers, MA, USA); TJAP-1 (1:1000; Novus Biologicals); Transfection:Article Title: MiRNA-132/212 regulates tight junction stabilization in blood–brain barrier after stroke Article Snippet: The following antibodies were used: CRTC1 (1:1000; Cell Signaling Technology, Danvers, MA, USA); TJAP-1 (1:1000; Novus Biologicals); Expressing:Article Title: MiRNA-132/212 regulates tight junction stabilization in blood–brain barrier after stroke Article Snippet: The following antibodies were used: CRTC1 (1:1000; Cell Signaling Technology, Danvers, MA, USA); TJAP-1 (1:1000; Novus Biologicals); |
